SUNSHINE HOLDINGS PLC (SUN.N0000)

Tea Brand Market Share

1. Sunshine Consumer Lanka Limited (48%)

(Zesta , Watawala , RanKahata)

2. EKATERRA - Formerly Unilever Ceylon LTD (24%)

(Lipton , Laogee)



Recording a 133.8% increase in revenue compared to the corresponding period of last year, the Consumer Goods Sector recorded a revenue close to Rs. 14.1 billion. Excluding the new addition of Sunshine Tea Export Business, revenue growth stood at 30.7%.

Both tea and confectionary categories have seen a noteworthy increase in revenue during the period in review. The PAT of the sector amounted to Rs. 498 million (up 115.7% YoY) compared to the same period last year.

https://www.sunshineholdings.lk/images/financial-reports/int-qua-reports/2022-2023/earnings-presentation-sun-3qfy23.pdf

Confectionery Market Share

1. Daintee Limited (Sunshine Consumer Lanka Limited)

2. Perfetti Van Melle Lanka PVT LTD

3. Darley Butler (E. B. CREASY & CO PLC - Colombo Fort Land & Building PLC)


The Consumer sector reported revenue of LKR 14.1bn in 9MFY23, with an increase of 133.8% YoY compared to the corresponding period last year and accounted for 36.5% of group revenue for the period. The revenue increase was predominantly driven by the addition of export business. Organic revenue growth stood at 30.7% YoY, driven by price increases to reflect higher input cost. Our Consumer brands Zesta, Watawala, Ran Kahata and Daintee continued to grow market shares, despite challenging consumer sentiment



Confectionery segment revenue grew by 75.8% YoY, supported by price increases

Sunshine Healthcare Lanka Ltd - Sri Lanka's First Integrated Healthcare Company



*Healthcare revenue up 36.3% YoY to Rs. 17.6 b



Pharma Manufacturing Segment Performance

*Lina Manufacturing delivers the first ever locally-produced Metered Dose Inhalers to Ministry of Health*

• Achieved over LKR 300 million in revenue in 3QFY23, demonstrating continued growth and success.

• Operating 24/7 from December 2022.

• Achieved break-even in operating profit for 9MFY23, marking a significant milestone towards sustained profitability and growth.



In December 2020, Sunshine Holdings announced its healthcare business’s strategic merger consisting of Sunshine Healthcare Lanka and Healthguard Pharmacy with Akbar Pharmaceuticals, Lina Manufacturing and Lina Spiro—the business units of Akbar Healthcare. The merger’s finalisation elevated Sunshine Healthcare as Sri Lanka’s first fully integrated healthcare company, starting from manufacturing up to retailing healthcare products, including last-mile distribution across the country for all healthcare products. The company now operates in all five segments of the healthcare supply chain, namely research and development (R&D), manufacturing, importation, distribution and retail.

The company is committed to investing in expanding its production capabilities to facilitate and decrease exposure to imports and international supply chains, ensuring the resilience of Sri Lanka’s national healthcare systems.​

Sri Lanka’s local pharmaceutical products market is worth Rs. 130 billion, yet the contribution of local pharmaceutical manufacturers is a mere Rs. 16 billion. One of the companies that have been contributing to this local share is Lina Manufacturing (Pvt) Ltd., the pharmaceutical manufacturing arm of homegrown conglomerate Sunshine Holdings PLC.

Being a relatively new addition to the resilient Sunshine Group, Lina is striving to increase local pharmaceutical manufacturers’ share in the market while also having export plans for the long term.​

https://www.themorning.lk/articles/F1rS9Luk3ta4jey7Z8Rl

Further committing to its nation-building efforts, Lina Manufacturing - the pharmaceutical manufacturing segment of Sunshine Healthcare Lanka (SHL), recently signed a contract manufacturing agreement with TRUVIC Private Limited. The partnership will help Lina to fulfill its corporate purpose of bringing good things to the lives of Sri Lankans through quality, affordable pharma products.

Lina Manufacturing has been engaged in the pharmaceutical manufacturing sector for over ten years and is a thriving local manufacturer supplying a large variety of respiratory products to the Government sector and private sector. Lina has pioneered the development of local respiratory products with its patented Respiratory Inhaler Device and continues to invest significantly in R&D to introduce more products. As Sri Lanka’s first Respiratory Care Research and Manufacturing facility, Lina Manufacturing produces a range of respiratory pharmaceuticals and devices, including Beclovent, Flutivent, Salbuvent, Prazolin, Winterpan and the award-winning Ventohaler inhalers.

In December 2020, Sunshine Holdings announced its healthcare business’s strategic merger consisting of Sunshine Healthcare Lanka and Healthguard Pharmacy with Akbar Pharmaceuticals, Lina Manufacturing and Lina Spiro—the business units of Akbar Healthcare. The merger’s finalisation elevated Sunshine Healthcare as Sri Lanka’s first fully integrated healthcare company, starting from manufacturing up to retailing healthcare products, including last-mile distribution across the country for all healthcare products. The company now operates in all five segments of the healthcare supply chain, namely research and development (R&D), manufacturing, importation, distribution and retail.

TRUVIC Private Limited markets high-quality pharmaceutical and consumer healthcare products, which are offered at affordable prices to the general public in Sri Lanka and other Asian countries. Driven by the visionary leadership of its founder Palitha Thenuwara, TruVic has reached millions of people through its ever-growing supply and distribution network. The company is strengthened by its partnerships with pharmaceutical industry leaders in India, Bangladesh, Pakistan Australia and Sri Lanka and other principals worldwide.

***Lina Manufacturing has accomplished a significant milestone by achieving One Billion Rupees in revenue.

‘’This remarkable achievement is a testament to the hard work, dedication, and innovation of Lina Manufacturing's exceptional team.
We remain committed to providing exceptional quality and value to our stakeholders, and we look forward to continued success and growth in the future. Congratulations to Lina Manufacturing on this remarkable milestone!’’ _ SUN


**Only 13% of national pharma demand supplied locally

Sri Lanka’s local pharmaceutical products market is worth Rs. 130 billion, yet the contribution of local pharmaceutical manufacturers is a mere Rs. 16 billion. One of the companies that have been contributing to this local share is Lina Manufacturing (Pvt) Ltd., the pharmaceutical manufacturing arm of homegrown conglomerate Sunshine Holdings PLC.

Being a relatively new addition to the resilient Sunshine Group, Lina is striving to increase local pharmaceutical manufacturers’ share in the market while also having export plans for the long term.​


https://www.themorning.lk/articles/F1rS9Luk3ta4jey7Z8Rl